Cognitive Dysfunction After Analgesia and Sedation: Out of the Operating Room and Into the Pediatric Intensive Care Unit

• Published in: Frontiers in behavioral neuroscience Vol. 15; p. 713668
• Main Authors: Turner, Ashley D., Sullivan, Travis, Drury, Kurt, Hall, Trevor A., Williams, Cydni N., Guilliams, Kristin P., Murphy, Sarah, Iqbal O’Meara, A. M.
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Research Foundation 16.08.2021; Frontiers Media S.A
• Subjects: Academic achievement; Adaptation; Analgesia; Anesthesia; Animal models; Benzodiazepines; Children; Cognition & reasoning; Cognitive ability; cognitive dysfunction; delirium; Elective surgery; Extracorporeal membrane oxygenation; Illnesses; Inflammation; Intensive care; Learning disabilities; Memory; Narcotics; Neurodevelopment; Neurological complications; Neuroscience; Neurotoxicity; Neurotransmission; opioid; Opioids; Pain perception; pediatric intensive care outcomes; pediatric post-intensive care syndrome; Pediatrics; Population; Risk factors; sedative neurotoxicity; Sedatives; Sepsis; Sleep; Survival; Synaptic plasticity; Traumatic brain injury; United States > US; pediatric intensive care outcomes; pediatric post-intensive care syndrome; neurodevelopment; sedative neurotoxicity; opioid; cognitive dysfunction; benzodiazepine; delirium
• ISSN: 1662-5153; 1662-5153
• DOI: 10.3389/fnbeh.2021.713668

In the midst of concerns for potential neurodevelopmental effects after surgical anesthesia, there is a growing awareness that children who require sedation during critical illness are susceptible to neurologic dysfunctions collectively termed pediatric post-intensive care syndrome, or PICS-p. In contrast to healthy children undergoing elective surgery, critically ill children are subject to inordinate neurologic stress or injury and need to be considered separately. Despite recognition of PICS-p, inconsistency in techniques and timing of post-discharge assessments continues to be a significant barrier to understanding the specific role of sedation in later cognitive dysfunction. Nonetheless, available pediatric studies that account for analgesia and sedation consistently identify sedative and opioid analgesic exposures as risk factors for both in-hospital delirium and post-discharge neurologic sequelae. Clinical observations are supported by animal models showing neuroinflammation, increased neuronal death, dysmyelination, and altered synaptic plasticity and neurotransmission. Additionally, intensive care sedation also contributes to sleep disruption, an important and overlooked variable during acute illness and post-discharge recovery. Because analgesia and sedation are potentially modifiable, understanding the underlying mechanisms could transform sedation strategies to improve outcomes. To move the needle on this, prospective clinical studies would benefit from cohesion with regard to datasets and core outcome assessments, including sleep quality. Analyses should also account for the wide range of diagnoses, heterogeneity of this population, and the dynamic nature of neurodevelopment in age cohorts. Much of the related preclinical evidence has been studied in comparatively brief anesthetic exposures in healthy animals during infancy and is not generalizable to critically ill children. Thus, complementary animal models that more accurately “reverse translate” critical illness paradigms and the effect of analgesia and sedation on neuropathology and functional outcomes are needed. This review explores the interactive role of sedatives and the neurologic vulnerability of critically ill children as it pertains to survivorship and functional outcomes, which is the next frontier in pediatric intensive care.